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Oestrogen receptor α AF-1 and AF-2 domains have
cell population-speciﬁc functions in the mammary
epithelium
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Oestrogen receptor α (ERα) is a transcription factor with ligand-independent and ligand-
dependent activation functions (AF)-1 and -2. Oestrogens control postnatal mammary gland
development acting on a subset of mammary epithelial cells (MECs), termed sensor cells,
which are ERα-positive by immunohistochemistry (IHC) and secrete paracrine factors, which
stimulate ERα-negative responder cells. Here we show that deletion of AF-1 or AF-2 blocks
pubertal ductal growth and subsequent development because both are required for expres-
sion of essential paracrine mediators. Thirty percent of the luminal cells are ERα-negative by
IHC but express Esr1 transcripts. This low level ERα expression through AF-2 is essential for
cell expansion during puberty and growth-inhibitory during pregnancy. Cell-intrinsic ERα is
not required for cell proliferation nor for secretory differentiation but controls transcript levels
of cell motility and cell adhesion genes and a stem cell and epithelial mesenchymal transition
(EMT) signature identifying ERα as a key regulator of mammary epithelial cell plasticity.
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Oestrogens, 17β-estradiol (E2) and its metabolites, arepivotal for the development and the physiology of thebreast and impinge on breast carcinogenesis. The oes-
trogen receptor α (ERα) is expressed in 40% of the luminal cells
that make up the inner layer of the mammary epithelium sur-
rounded by basal/myoepithelial cells1. Oestrogens drive pubertal
development in the mouse mammary gland and induce expres-
sion of the progesterone receptor (PgR), activation of which
drives cell proliferation during subsequent oestrous cycling and
pregnancy. Both hormones rely on paracrine factors to activate
stem cells and induce proliferation of other mammary epithelial
cells (MECs)2.
The ERα belongs to the nuclear receptor family and is com-
posed of six modular domains, namely, A to F3. Ligand-
independent and ligand-dependent activation functions, AF-1
and AF-2 map to the A/B and E domains, respectively4,5. Ligand-
independent signalling results from phosphorylation of different
serine residues in AF-1 by for instance MAPK6, GSK-37 or
cyclinA/cdk28. Upon activation, the receptor dimerises and
translocates to the nucleus where it interacts either directly with
the DNA via speciﬁc DNA sequences known as the oestrogen
response elements, or indirectly via DNA-binding proteins like
AP-19. Full ligand-dependent transcriptional activity relies on
synergistic activities of AF-1 and AF-25. A small fraction of the
ERα is found at the plasma membrane; it elicits rapid, non-
genomic responses, which modulate multiple signalling pathways
and create cross-talk between membrane and nuclear ERα10.
More than 70% of all breast cancers express the ERα and this is
exploited therapeutically. The most widely used agent, tamoxifen,
antagonises AF-211 and agonises AF-112, and is used in primary
and secondary breast cancer prevention. Most insights into the
molecular mechanisms underlying ERα signalling stem from
in vitro studies with ERα-positive (ERα+) breast cancer cell lines,
in particular MCF-7 cells which express very high levels of the
receptor and are exquisitely sensitive to E2. How ER signalling
occurs in vivo in normal and cancerous tissue is poorly under-
stood. To dissect the different aspects of ERα signalling in vivo,
mice lacking speciﬁcally the AF-1 domain (AF-10)13 or the AF-2
domain (ERαAF-20)14 were generated and compared to mice
lacking the entire ERα (ERα−/−); all three strains are viable but
have impaired reproductive functions, and distinct organ
defects13–15. The role of the AF-1 and the AF-2 domains in the
mammary epithelium was not analysed. Using ERα−/− mice, we
have previously shown that ERα is required for ductal elongation
in the mammary epithelium16.
Here, we explore the role of AF-1 and AF-2 vs. intact ERα
signalling in mammary gland development; we demonstrate dif-
ferential roles that are dependent on cell type and/or ERα protein
levels and uncover important functions of the ERα in apparently
ERα-luminal responder cells.
Results
Mammary gland development in ERαAF-10 and ERαAF-20
mice. To assess the impact of germ-line deletion of ERα ligand-
dependent, AF-2, vs. ligand-independent, AF-1, genomic actions
on mammary gland development, we analysed mammary glands
of AF-10 and AF-20 females and their respective WT littermates
(Fig. 1a) at critical developmental stages using whole-mount
stereomicroscopy (Fig. 1b, Supplementary Figure 1a–d). Before
the onset of ovarian function, on postnatal day 21, all females had
rudimentary ductal systems (Supplementary Figure 1a) with on
average 4.7% fat pad ﬁlling in WT and <3% fat pad ﬁlling in the
ERα mutant littermates (Fig. 1c, Supplementary Figure 1a). In
pubertal, that is 4- to 7-week-old WT females, rapidly growing
ductal tips enlarged to form terminal end buds (TEBs) and ducts
extended beyond the sub-iliac lymph node to ﬁll 61% of the fat
pad (Fig. 1b, c). In AF-10 and AF-20 littermates, no TEBs were
found and fat pad ﬁlling remained <3% (Fig. 1b, c). In adult, 8- to
12-week-old WT females, fat pads were ﬁlled up to 80%, in their
AF-10 and AF-20 littermates to 5.1% and 3% only, respectively
(Fig. 1c, Supplementary Figure 1b). In older WT females, which
have been exposed to repeated oestrous cycle related peaks of E2
and progesterone, side branching occurred (Supplementary Fig-
ure 1c, d; Fig. 1c) whereas the block of ductal growth persisted in
AF-20 females (Supplementary Figure 1b, c) as observed in
ERα−/− females16. In older AF-10 females, few ducts occasionally
extended beyond the lymph node (Supplementary Figure 1c, d,
Fig. 1c). Mutant ducts were atrophic with decreased ductal dia-
meters (Supplementary Figure 1c, d) but structurally intact with
luminal and basal cell layers as revealed by histological analysis
(Supplementary Figure 1e). Immunohistochemistry (IHC)
revealed expression of ERα protein in AF-10 and AF-20 mammary
epithelia at levels comparable to WT controls (Fig. 1d), as
reported for their uteri13,14. This excluded the possibility that the
mutant ERα proteins were unstable and their expression in MECs
was reduced or lost. Thus, the phenotypes reﬂect the speciﬁc
deletions of AF-1 or AF-2 domain and show that both are
required for ERα function during ductal elongation.
Endocrine disturbances in AF-10 and AF-20 mice. Adult AF-10,
AF-20 and ERα−/− female mice were reported to have increased
serum levels of E2, luteinizing hormone and testosterone as mea-
sured by radioimmunoassay17. Our ﬁnding that mammary gland
development was already affected before puberty begged the ques-
tion whether endocrine disturbances may occur earlier. As plasma
steroid hormone levels are very low prior to puberty, we used liquid
chromatography tandem–mass spectrometry (LC–MS). We con-
ﬁrmed that both E2 and testosterone levels increased signiﬁcantly in
all three mutants in adulthood. E2 was detected at levels of 12 pg/ml
in plasma of WT females and increased almost 2-fold in AF-10 and
threefold in AF-20 and ERα−/− females. Testosterone levels raised
from on average 0.1 ng/ml in plasma of WT females to 0.7 ng/ml
plasma levels in AF-10, 1.5 ng/ml in AF-20 and 1.4 ng/ml in ERα−/−
females (Fig. 2a). Plasma progesterone levels varied in WT females
due to oestrous cycling not observed in the mutants in which
ovarian cycles are not established. All three mutants had decreased
11-deoxycorticosterone levels while 17-OH-progesterone levels
were increased in ERα−/− females (Fig. 2a).
Progesterone levels increased speciﬁcally in peripubertal AF-20
females whereas androstenedione levels increased in peripubertal
ERα−/− and pubertal AF-20 females (Fig. 2a). Testosterone was
signiﬁcantly increased in peripubertal AF-10 females. Hence,
complex alterations of the endocrine milieu occurred already
before and during puberty.
An overall analysis of the average fold-changes in steroid levels
in ERα mutants compared to WT and heterozygous littermates in
relation to their biosynthetic pathways revealed comparable
decrease of plasma levels of the progesterone derivatives, 11-
deoxycorticosterone and corticosterone, in all mutants in
adulthood (Fig. 2b). The levels of E2 and its precursors 17OH-
progesterone, androstenedione, and testosterone, were close to
WT levels in AF-10 mice but deviated similarly in ERα−/− and
AF-20 females are in line with negative feedback loops of the E2
biosynthetic pathway being regulated by ligand-dependent ER
activity.
Mammary epithelial-intrinsic role of AF-1 and AF-2 domains.
The systemic effects of the germ-line mutations and the resulting
complex endocrine abnormalities confounded the interpretation of
the mammary gland phenotype. To assess the MEC intrinsic
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requirement of each domain, we grafted fragments of ducts from
AF-10.GFP+ or AF-20.GFP+ and WT.GFP+ littermates into con-
tralateral inguinal mammary glands of 3-week-old WT hosts sur-
gically divested of endogenous epithelium18. Fluorescence
stereomicroscopy of the engrafted glands 10 weeks after surgery
showed that grafted WT epithelia ﬁlled the fat pads (Fig. 3a, e) but
the AF-10.GFP+ fragments failed to grow (Fig. 3b, e). During
pregnancy, WT.GFP+ grafts formed complex ductal trees with
alveoli (Fig. 3c, e). Only 1 out of 5 AF-10.GFP+ grafts showed some
ductal growth with 15% fat pad ﬁlling; alveoli were absent (Fig. 3d,
e). When the WT grafts developed normally (Fig. 3f, h, j), the
contralateral AF-20.GFP+ grafts grew neither in nulliparous nor
pregnant hosts (Fig. 3g, i, j). Thus, both AF-1 and AF-2 are required
in MECs for ductal outgrowth19,20, side branching, and alveolo-
genesis. AF-1 abrogation is compatible with limited ductal elonga-
tion during pregnancy, whereas AF-20 MECs fully recapitulate the
ERα−/− MEC phenotype with a complete developmental block16.
Steroid hormones induce mammary gland development largely
through paracrine signalling2. Areg is an essential mediator of E2-
induced cell proliferation during puberty19 and Wnt4 an
important activator of stem cells, which can be induced by E2
in pubertal mammary glands21. In mammary glands from
pubertal age AF-10 and AF-20 mice, Areg and Wnt4 transcript
levels were as low as in their ERα−/− counterparts, i.e.,<1 or 10%,
respectively, as compared to WT (Fig. 3k). Thus, transcription of
Areg and Wnt4 requires both ERα AF-1 and AF-2, providing a
mechanism for the growth defect in the mutant epithelia.
Transcript levels of other ERα targets, Pgr122 and Prlr23, were
similarly decreased (Fig. 3k). However, speciﬁcally Pgr1 levels
were higher in AF-10 than in AF-20 and ERα−/− mammary
glands (Fig. 3k). The PgR protein was readily detected by IHC in
luminal cells of WT and AF-10, but not of AF-20 or ERα−/−
females (Fig. 3l) indicating that PgR expression is largely AF-2
dependent and somewhat AF-1 independent.
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Fig. 1 Mammary gland phenotype of AF-10 and AF-20 mice. a Schematic representation of the mutant genomic loci and the ERα proteins expressed in WT
mice, AF-10 mice with deletion of amino acids 2–148, and AF-20 mice with deletion of amino acids 543–549. Only the main protein initiated by the
translational initiation codon in exon 1 on amino acid 1 (ATG) is shown for each genotype. The less abundantly expressed protein is initiated in exon 2 on
amino acid 178. b Whole-mount stereomicrographs of inguinal mammary glands from 7-week-old WT, AF-10 and AF-20 females. Arrowheads indicate
TEBs. Black lines mark the borders of the ductal outgrowth. Scale bars: 5 mm (left), 2 mm (right). LN sub-iliac lymph node. c Dot plot showing extent of fat
pad area ﬁlled by the engrafted WT, AF-10 and AF-20 epithelia at different developmental stages (n= 3–18). Shown are means ± SEM; unpaired, two-tailed,
Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, n.s. not signiﬁcant. d ERα IHC of mammary glands from 3-week-old WT, AF-10, AF-20 and
ERα−/− mice. Representative pictures of glands analysed from three females of each genotype are shown. Scale bar: 100 μm
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We hypothesised that the residual PgR expression in AF-10
epithelium may account for the partial outgrowth in this mutant
observed in the older females and during pregnancy. To test
whether prolonged PgR signalling is sufﬁcient to stimulate ductal
growth, we exposed mice bearing AF-10.GFP+ and WT.GFP+
epithelial grafts to pregnancy levels of progesterone by implanting
slow-release pellets subcutaneously. Serum progesterone levels at
sacriﬁce corresponded to those observed during pregnancy in
control animals (Supplementary Figure 2a). While the
contralateral WT.GFP+ grafts showed increased side branching
(Supplementary Figure 2b) conﬁrming successful delivery of
progesterone, the AF-10.GFP+ epithelial grafts remained rudi-
mentary (Supplementary Figure 2c) indicating that activation of
PgR signalling is not sufﬁcient to stimulate ductal elongation in
AF-10 epithelial grafts. These observations support a model where
the function of ER+ sensor cells relies on both AF-1 and AF-2 for
the transcription of Areg and Wnt4 and potentially other factors
and/or cell-intrinsic functions required for ductal elongation.
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The role of ERα in responder cells in ductal outgrowth. We
previously reported that when ERα−/−ROSA26+ MECs were
mingled with excess WT MECs and this mixture was then grafted
to cleared mammary fat pads, ERα−/− MECs contributed to the
chimeric outgrowth16 and gave rise to the model of sensor and
responder cells24,25. To compare the ability of AF-10, AF-20 and
ERα−/− MECs, none of which were able to grow out on their
own, to contribute to mammary gland development in the con-
text of excess WT MECs that release paracrine and potentially
other signals, we co-injected either ERαWT.GFP+ or ERα mutant.
GFP+ MECs mixed with WT.DsRed+ MECs in a 1:10 ratio
(Fig. 4a) into contralateral glands. The resulting WT.GFP+:WT.
DsRed+ chimeric glands appeared to 4% GFP+, almost 10 times
as many seemed DsRed+ (37%), while 59% scored double
positive by ﬂuorescence stereomicroscopy (Fig. 4b, c). In the ERα
−/−.GFP+:WT.DsRed+ chimeras, only 23% were double positive
whereas 77% appeared DsRed+ (Fig. 4b, c). This indicates that
ERα−/−.GFP+ MECs are able to proliferate when mixed with
WT.DsRed+ MECs, but are less efﬁcient than ERαWT.GFP+
MECs in contributing to ductal outgrowth. This demonstrates
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f–j Fluorescence stereomicroscopy of contralateral inguinal mammary fat pads engrafted with mammary epithelium from AF-20.GFP+ or WT.GFP+
littermates. Nulliparous (f, g) and (P16–18) pregnant (h, i) recipients are shown. Scale bars; 5 mm (top) 2mm (bottom). j Box plot showing extent of fat pad
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from peripubertal WT, AF-10, AF-20 and ERα−/− females. Data are shown as means ± SEM of three independent experiments. Paired two-tailed Student’s
t test, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, n.s. not signiﬁcant. l PgR IHC of mammary glands from 3-week-oldWT, AF-10, and AF-20, ERα−/− and
PR−/− mice. Representative pictures of glands analysed from three females of each genotype are shown. Scale bar; 100 μm
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that ERα is required not only in the ERα+ sensor cells but also in
the apparently ERα- responder MECs.
To assess whether ERα function in responder cells requires AF-
1 and AF-2, we generated chimeras with AF-10 or AF-20 cells. AF-
10.GFP+:WT.DsRed+ chimeras were comparable to the WT
chimeras (Fig. 4b, c). AF-20.GFP+:WT.DsRed+ chimeras were
more similar to ERα−/−.GFP+:WT.DsRed+ chimeras with 52%
appearing DsRed+ only and 48% double positive (Fig. 4b, c).
Thus, ERα function in the responder cells is AF-1 independent
but AF-2 dependent.
We approximatively evaluated the GFP signal (Fig. 3d) and the
ratio of GFP to RFP signal intensities (Fig. 4e) in chimeric
epithelia by analysis of a 2D-image of the chimeric gland and
showed that the data points were similarly distributed forWT and
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AF-10 chimeras whereas they tended to be lower for AF-20 and
ERα−/− chimeras (Fig. 4d, e). To determine the contribution of
GFP+ MECs quantitatively, we analysed chimeric glands by
FACS. After lineage+ cell depletion, we discriminated
CD24highCD49flow luminal and CD24lowCD49fhigh basal cells26.
WT.GFP+ cells represented 12.9 ± 3.5% of the luminal and
8.2 ± 2.7% of the basal cell population (Fig. 4f, g) reﬂecting the
original 10% GFP+ cells. The deviation from the predicted 10%
may reﬂect biological variation or cell type-speciﬁc differences in
expression from the chicken β-actin promoter driving GFP27,28.
AF-10.GFP+ MECs contributed similarly to both cell lineages.
AF-20.GFP+ and ERα−/−.GFP+ cells were signiﬁcantly less
represented with <1% of the luminal cells (Fig. 4f) and 6% and
1.7%, respectively, of the basal cells but the latter failed to reach
statistical signiﬁcance (Fig. 4g).
Thus, while both AF-1 and AF-2 are required for the
expression of essential paracrine mediators in sensor cells, the
responder cells require ERα but more speciﬁcally AF-2; AF-1 is
not required in responder cells during ductal elongation.
The role of AF-1, AF-2 and ERα during pregnancy. During
pregnancy, E2 levels increase from <10 to 100 pg/ml29 and there is
extensive cell proliferation of MECs, which are hormone receptor
negative by IHC30,31. Fluorescence stereomicroscopy at the end of
pregnancy showed that 90% of WT.GFP+:WT.DsRed+ chimeras
were mixed while 10% appeared DsRed+ only (Fig. 5a, b). Of the
AF-10.GFP+:WT.DsRed+ and AF-20.GFP+:WT.DsRed+ chimeras
43% scored double positive and 57% DsRed+ only whereas of the
ERα−/−.GFP+ chimeras 67% scored double positive (Fig. 5a, b).
Approximate evaluation of the GFP signal (Fig. 5c) and the ratio
of GFP to RFP signal intensity (Fig. 5d) based on a 2D image
showed similar distributions among the chimeras. Comparison of
the contribution of the different mutant cells to that of WT cells
before and at the end of pregnancy indicates that loss of ERα
function promotes cell expansion during pregnancy largely
through AF-2, whereas AF-1 loss may have an inhibitory effect on
cell expansion. Together, the observations on the chimeric out-
growths suggests that ERα function in the ERα low cells is biphasic
with a growth-stimulatory role during puberty and an inhibitory
role during pregnancy both of which appear AF-2 dependent and
AF-1 independent.
Evaluating ERα in vivo function in by intraductal grafting. The
surprising ﬁnding that ERα signalling appeared to have a biphasic
effect on MECs depending on the developmental stage incited us
to look at ERα in vivo function by an alternative approach that
bypasses the need of dissociated MECs to establish themselves in
the mammary fat pad because this does not happen physiologi-
cally during development and could lead to artefacts, which may
confound the interpretation of the results. Human breast epi-
thelial cells have difﬁculties in establishing themselves in the
mouse mammary fat pad but when injected into the milk ducts
they insert into the mouse mammary epithelium and proliferate
there32. We ascertained that the same holds true for murine
MECs by injecting WT.DsRed+ MECs intraductally into NOD
scid gamma (NSG).GFP+ females. Five days later, WT.DsRed+
MECs were detected in the GFP+ ducts by ﬂuorescence stereo-
microscopy (Fig. 6a). Double immunoﬂuorescence revealed that
most DsRed+ cells were luminal MECs, distinct from the P63+
basal cells (Fig. 6b); about 10% of the DsRed+ cells gave rise to
myoepithelial cells as identiﬁed by smooth muscle actin co-
staining (Fig. 6c).
Next, we injected MECs from WT.GFP+ and ERα−/−.GFP+
littermates into contralateral glands and analysed them 5 days
later by stereomicroscopy. The ﬂuorescent signal from ERα−/−.
GFP+ cells was consistently lower than the signal from the
contralateral WT.GFP+ cells (Fig. 6d, f). When hosts were mated
and their engrafted glands were analysed in late pregnancy, the
signals became comparable (Fig. 6e, f) suggesting that ERα−/−
MECs caught up with their WT counterparts as observed in the
context of the chimeric epithelial outgrowths above (Fig. 5a).
Quantiﬁcation of GFP+ cells by FACS revealed that WT.GFP+
cells represented 4.4% and ERα−/−.GFP+ cells <0.7% of the
dissociated cells in virgin mice whereas at day 14.5–16.5 of
pregnancy, the contributions of WT.GFP+ and ERα−/−.GFP+
MECs were comparable (Fig. 6g, h).
Having ascertained that the biphasic effect of ERα observed in
the context of chimeric outgrowths is reproduced in the
intraductal model, we evaluated the role of AF-1 and AF-2.
Because of the inter-experimental variability in the cell prepara-
tions, we normalised the individual ERα mutant cell numbers to
the contralateral WT cells. In the nulliparous hosts, all three ERα
mutants established themselves less well intraductally than their
WT counterparts; AF-10 MECs showed 35%, AF-20 MECs 83%,
and ERα−/−MECs 70% reduction, respectively (Fig. 6i). Towards
the end of pregnancy, none of the mutants differed signiﬁcantly
from the WT controls (Fig. 6j). Thus, by two distinct
experimental approaches a biphasic effect of ERα−/− through
AF-20 in MECs is revealed. AF-1 function which was not required
for ductal elongation in the context of chimeric glands did affect
the ability of MECs to establish themselves intraductally arguing
that it may affect cell–cell interactions required for the insertion.
The ﬁnding that as early as 5 days after cell injection the
number of WT.GFP+ MECs that have inserted into the ducts
exceeds that of AF-20 and ERα−/− MECs by several fold,
suggested that MECs require ERα to adhere and insert themselves
into the host epithelium.
To assess the proliferative indices of ERα−/− MECs and WT
MECs during puberty and pregnancy we took different
approaches. In one setting, we measured cell proliferation of
ERα−/−.GFP+.WT.DsRed+ and WT.GFP+.WT.DsRed+ chimeras
during ductal elongation by Ki67 staining because the number of
ERα−/− MECs obtained after intraductal injection is very low in
virgin recipients. In the other setting, we injected EdU into
pregnant mice, which had been intraductally engrafted with ERα
Fig. 4 Contribution of AF-10, AF-20 and ERα−/− cells to chimeric ducts with WT MECs. a Scheme of experimental design. After cell dissociation, 10,000
ERα mutant (ERmt) or WT GFP+ epithelial cells were mixed with 90,000 WT.DsRed+ epithelial cells and injected into the cleared mammary fat pad of
peripubertal recipient mice. b Representative ﬂuorescence stereomicrographs of chimeric epithelia from WT.GFP+ or ERα.mutant.GFP+ and WT.DsRed+
cells mixed in a 1:10 ratio. Hosts were analysed 10 weeks after engraftment. Scale bars; 1 mm (left) 0.2 mm (right). c Pie charts showing the proportion of
engrafted mammary glands appearing exclusively DsRed+, exclusively GFP+, or mixed (red and green stripes) based on evaluation at low (7.8×)
magniﬁcation of ﬂuorescence stereomicrographs. From top to bottom, n= 51, 21, 17 and 13. d Dot plot showing the percentage of the reconstituted ductal
epithelium that is GFP+ in virgin mice based on images at 7.8× magniﬁcation, (n= 13–51) bars indicate medians. e Dot plot showing the ratio of GFP/
DsRed signal intensity of the reconstituted ductal epithelia based on images at 7.8× magniﬁcation, bars indicate medians (n= 29, 15, 7 and 7). f, g Bar
graphs showing ﬂow cytometric analysis of the percentage of GFP+ cells in the CD24high CD49flow f and CD24low CD49fhigh g cell populations of
reconstituted chimeric mammary epithelia. From left to right, n= 20, 5, 8 and 6. Shown are means ± SEM; Mann–Whitney test, two-tailed, **p < 0.01, ****p
< 0.0001, n.s. not signiﬁcant
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−/−.GFP or AF-20.GFP MECs contralateral of WT.GFP MECs
and subsequently quantiﬁed the GFP and EdU double positive
cells. In both scenarios the proliferative indices were comparable
between WT and ER mutant MECs (Fig. 6k, l). Thus, the absence
of ER does not impair cell-intrinsic proliferation.
We hypothesised that the results may related to different
numbers of stem/progenitor cells present in the mutant
mammary epithelia. However, because of the low number of
MECs that can be isolated from the ERα mutant mammary
glands it was not practical to FACS purify any particular
subpopulations for in vivo experiments. To assess whether the
luminal and basal progenitor cell populations are affected by
different ERα mutations, we FACS proﬁled mammary gland cells
after lineage+ cell depletion with CD24 and CD49f26,33. While
the WT proﬁles were consistent between independent experi-
ments, the AF-10, AF-20 and ERα−/− MECs showed major shifts
in both CD24 and CD49f expression, making it impossible to
identify the different progenitor populations (Fig. 6m).
ERα-dependent gene expression in mammary epithelial cells.
To discern the molecular basis of the ERα−/− MEC phenotypes,
and to further test for evidence that stem cell function is impaired
by abrogating ERα signalling, WT.GFP+ and ERα−/−.GFP+
MECs were intraductally injected to contralateral glands, isolated
from pregnant hosts by FACS sorting for GFP, and analysed by
RNA sequencing. Principal component analysis separated
samples by ERα genotype (Fig. 7a). A total of 651 genes were
differentially expressed, most of which were lower in the ERα−/−.
GFP+ MECs (>twofold, FDR < 0.05) (Fig. 7b).
Expression levels of genes that mark ERαhigh MECs34,
including Esr1 itself, were low and no signiﬁcant differences
were found consistent with the scarcity of ERα+ MECs in the
pregnant mammary epithelium (Fig. 7c). Milk protein coding
genes, were highly expressed in both WT and ERα−/− MECs
(Fig. 7d) establishing that ERα is not required for functional
differentiation, at least not cell intrinsically. MetaCore terms
related to cytoskeleton and cell adhesion were decreased in the
ERα−/− MECs (Fig. 7e) providing potential molecular under-
pinnings for impaired intraepithelial insertion. MetaCore terms
related to immune signalling were increased in ERα−/− MECs
(Fig. 7f). Reactome35 analysis revealed decreased keratinisation
(Fig. 8a) and conﬁrmed increased expression of immunity-related
genes in ERα−/− MECs (Fig. 7g). Moreover, Ephrin and FGFR
signalling as well as ECM remodelling were decreased (Fig. 7h);
all three have been implicated in pubertal growth36,37 but had not
previously been linked to ERα signalling directly. GO terms and
KEGG terms highlighted that the upregulated genes relate to T-
cell immunity (Fig. 7i–j).
We noticed basal markers like Krt5, Snai2, P63 and Frizzled7
among the most differentially expressed genes (Fig. 8a). Gene set
enrichment analysis for hallmark gene sets38 showed that an EMT
signature was most similar with p= 10E28 and compared to
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Paired two-tailed Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, n.s. not signiﬁcant
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curated gene sets a mammary stem cell signature scored highest
with p= 8E105 (Fig. 8b, c). Thus, ERα expression is not required
for milk gene expression but is important for the transcriptional
control of mammary stem/progenitor cell function as well as
cellular interactions.
ERα status of luminal epithelial cells. Our ﬁnding that ERα has
an important role in cells that appear ERα negative by IHC
begged the question whether IHC may fail to detect functionally
relevant ERα protein expression. Hence, we sought to detect ERα
transcripts in situ in sections adjacent to sections assessed by IF
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for ERα protein expression. While ERα protein was detected in
50% of the luminal cells (Fig. 9a, c), RNAscope detected ERα
mRNA in 80% of the luminal cells (Fig. 9b, c) indicating tran-
script expression in luminal cells other than the 50% ERα+ by
IHC, the protein may be expressed at levels below the IHC
detection limit possibly because of rapid turnover. Semi-
quantitative scoring based on the number of dots per cells
showed approximately 20% of the luminal cells falling into the
negative, the low (1) and medium (2) categories and 40% into the
high (≥3) (Fig. 9d), Of note, transcripts of the ERα target Areg
were only detected in a subset of 15–30% of luminal cells
(Fig. 9e), which we assume to be ERαhigh sensor cells because they
co-express PgR protein, here used as a proxy for ERα since the
antibodies for ER do not work with RNAscope (Fig. 9e–g).
Thus, with respect to ERα status, at least three different luminal
cell types can be distinguished. The sensor cells, ERα+ by IHC,
the responder cells, which are ERα- by IHC yet express detectable
amounts of ERα transcript, and ERα negative responder cells.
Sensor cells require both AF-1 and AF-2 whereas the ERαlow
responder cells are AF-2-dependent. These three groups may
represent three distinct classes of luminal epithelial cells or
different zones of a gradient of different ERα expression levels.
Discussion
The present study of the in vivo role of ERα and its subdomains
AF-1 and AF-2 in the mammary epithelium reveals unexpected
complexities of this signalling pathway. Contrary to current
thinking that there is a dichotomy between ERα+ and ERα-
luminal cells, we show that based on ER expression levels, a third
luminal cell population, the ERαlow cells, can be distinguished.
These cells have readily detectable Esr1 transcripts but are char-
acterised by low-level ERα protein expression, possibly attribu-
table to high protein turnover. The percentage of luminal cells
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Fig. 7 Global gene expression proﬁle of ERα−/− and WT MECs. a Principal component (PC) analysis of RNAseq data showing the importance of the Esr1
genotype for global gene expression. b Bar graph showing the number of genes whose expression increased (IE) or decreased (DE) in ERα−/−.GFP+ vs.
WT.GFP+ MECs engrafted intraductally to contralateral glands of NSG females and subsequently isolated by FACS-sorting from hosts during pregnancy.
c Bar plot showing reads per kilobase million (RPKM) of ERα high, sensor cell markers expressed in ERα−/−.GFP+ and WT.GFP+MECs that were engrafted
intraductally to contralateral glands of NSG hosts and subsequently isolated by FACS-sorting from pregnant hosts. d Bar plot showing RPKM of milk genes
expressed in FACS-sorted ERα−/−.GFP+ and WT.GFP+ MECs grafted intraductally and isolated from pregnant hosts. e, f MetaCore analysis of genes
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with high Esr1 mRNA levels as determined by RNAscope
amounted to 40% whereas the percentage of ERα+ cells by IHC
in adjacent sections was somewhat higher with 50% suggesting
that mRNA and protein levels do not directly correlate. Whether
the ERαhigh and ERαlow luminal cell populations that we propose
correspond to the mature and progenitor sensor cells recently
discerned by single cell RNA sequencing39,40 remains to be tested.
Similarly, whether the different ERα states mark distinct cell
populations or reﬂect different transient and/or functional states
of otherwise similar luminal cells, will need to be addressed by
more in depth single cell sequencing. Lineage tracing experiments
have shown that ERα+ cells only give rise to ERα+ cells41,42. In
one approach, the prominin promoter was used to drive Cre
expression and shown to be expressed in a subset of ERαhigh
cells42. In the other approach, a 4-kb fragment upstream of the
Esr1 transcription start site was used to drive doxycycline-
inducible transgenic Cre expression; subsequently the founder
was selected which showed the best overlap of Cre expression
with ERαhigh cells41. It will be interesting to see how the outcome
would change if the ERαlow luminal cell populations were traced.
If indeed would these cells give rise exclusively to ERαlow luminal
cells suggesting that ERα status is ﬁxed or they may be less dif-
ferentiated and more plastic and be able to give rise also to ERα-
cells.
Furthermore, it remains to be ascertained with more sensitive
quantitative approaches whether ERα status is truly tripartite in
the luminal epithelium or whether underlying our observations is
a continuous, possibly changing gradient in ERα expression
levels.
The current model, about the cellular origin of breast cancer
has it that ERα+/luminal breast cancers originate from ERα+
while triple negative/basal-like breast cancers from ERα-cells. Our
ﬁndings beg the question how the ERαlow vs. ERαhigh luminal
cells contribute to breast cancer development. Similarly, the
current view of ERα as a marker of differentiation in a hier-
archical model for mammary cell types appears too simple. At
least when expressed at low levels, ERα may have an important
role in controlling cell plasticity.
A picture emerges that links ERα function and signalling
mechanisms to its expression level. ERαhigh sensor cells require
both AF-1 and AF-2 to transcribe essential paracrine mediators,
like Areg, Wnt4 and Pgr1 and to induce ductal growth. It is
tempting to speculate that this is a means of ensuring that the
strongly pro-proliferative actions of paracrine signalling only kick
in when both sufﬁcient levels of the ER ligand itself are around
and growth factor signalling is simultaneously active resulting in
ER phosphorylation and activation of AF-1. ERαlow responder
cells largely rely on AF-2 to transcriptionally control the cytos-
keleton, cell adhesion, and signalling, essential for the expansion
of this cell population during ductal morphogenesis with its
extensive cell movements in response to paracrine signalling. The
effects of AF-1 deletion appear more subtle in the responder cells.
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Fig. 9 ERα mRNA and protein expression ERα−/− and WT MECs. a ERα immunoﬂuorescence (red) and b RNAscope with anti-Esr1 probes (red) on an
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We failed to detect a phenotype in the context of chimeric epi-
thelia during ductal outgrowth, yet the AF-10 MECs were less
efﬁcient than their WT counterparts during intraductal engraft-
ing suggesting that AF-1 may affect the expression of cell adhe-
sion genes a hypothesis that seems plausible in light of the altered
CD24 and CD49f expression in this mutant.
During pregnancy, ERα−/− MEC populations expand more
than their WT counterparts. However, we failed to detect a dif-
ference in proliferation indices at the speciﬁc pregnancy time
point we analysed, e.g., day 12.5. Two scenarios are conceivable;
either at an earlier or a later time point, f.i. during alveologenesis
the ERα MECs have higher proliferative indices than their WT
counterparts, this can be addressed by more detailed follow up
studies. Alternatively, pregnancy-induced cell proliferation
may be faster in ERα negative MECs than in ERαlow or ERαhigh
cells. As only 20% of the luminal cells in the WT setting are ERα
negative whereas in the ERα−/−MECs 100% lack ERα expression
this could underlie the observed compensation in the course of
pregnancy.
The opposite biological effects in puberty and pregnancy may
also reﬂect a dose-dependent biphasic mode of action with low
oestrogen levels in puberty and high levels during pregnancy
triggering opposite actions. Alternatively, it may relate to the
speciﬁc hormonal context, which changes dramatically from
puberty to pregnancy, this concerns a multitude of hormones but
is particularly striking for progesterone. In addition to changes in
the levels of the ligands the concomitant loss of PgR expression,
which opposes many ERα actions43 may have a role to play.
Previously, ERαNeoKO mice44 were suggested to be an AF-1
deﬁcient mouse model as they transcribe a spliced mRNA that
gives rise to a receptor lacking parts of the domain A and all
domain B45. In contrast to the present ﬁnding that ERαAF-10
mammary epithelia fail to develop alveoli, some of the
ERαNeoKO epithelial grafts grew during pregnancy and devel-
oped alveoli16. It is conceivable that complete loss of ERα func-
tion in some MECs accounts for this; the activity of the resulting
E1 ERα variant protein in the ERαNeoKOmice is animal and cell-
type dependent46.
Our ﬁnding that all ERα signalling is AF-2-dependent provides
a molecular basis for the breast speciﬁc efﬁcacy of the widely used
breast cancer therapeutic, tamoxifen, which is an AF-2 antagonist
but AF-1 agonist47.
Methods
Mice. All mice were maintained and handled according to Swiss guidelines for
animal safety with a 12-h-light-12-h-dark cycle, controlled temperature and food
and water ad libitum. Animal experiments were performed in accordance with
protocols approved by the Service de la Consommation et des Affaires Vétérinaires
of Canton de Vaud, Switzerland. The ERα−/−15, ERαAF-1[013, ERαAF-2[014
RAG1−/−48, C57BL/6-Tg(Act-EGFP)27 and tg(CAG-DsRed*MST)1Nagy/J28 were
maintained in C57Bl6 background. The NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice
(NSG) were purchased from Jackson Laboratories. Mice were anaesthetised by
intraperitoneal injection with 10 mg/kg xylazine and 90 mg/kg ketamine (Graeub).
Transplantations and intraductal injections. For transplantations, 1 mm3 epi-
thelial fragments were prepared under a ﬂuorescence stereoscope from GFP+
donor mice and inserted into the inguinal fat pads of 3-week-old Rag1−/− females
cleared of their endogenous epithelium as described49. To generate chimeric epi-
thelia, 90,000 dissociated WT.DsRed+ mixed with 10,000 dissociated mutant.GFP+
cells in 10 μL of 20% growth factor reduced matrigel (BD Biosciences) were injected
into cleared fat pads. Mutant and control fragments were grafted into contralateral
glands. The outgrowths were analysed 10 weeks after transplantation or after
impregnation of the hosts on P16–18. Progesterone and control pellets were pre-
pared as described50 and inserted subcutaneously in the neck region of 12-week-old
females. Intraductal injections were performed as described32.
Mammary gland whole-mounts and image analysis. Mammary gland whole-
mounts were performed as described51. Stereomicrographs were acquired using a
LEICA MZ FLIII stereomicroscope with Leica MC170 HD. Fluorescence images
were acquired using a LEICA M205FA ﬂuorescence stereomicroscope with Leica
DFC 340FX camera. The area of mammary fat pad ﬁlled by ducts and branching
points were determined using ImageJ software. To determine the area of fat pad
ﬁlled with epithelium, areas with ducts were circled using ImageJ software. The
total area of the mammary fat pad, ﬁlled and not ﬁlled, was measured using the
same method and the percentage of fat pad occupancy determined as ratio between
duct area/total fat pad area. GFP and DsRed signal intensities were calculated with
(integrated densitysignal− areasignal) × meanbackground using ImageJ software.
Immunoﬂuorescence and antibodies. Glands were ﬁxed with 4% paraformalde-
hyde overnight at 4 °C and embedded in parafﬁn. Sections measuring 4 μm were
dewaxed, rehydrated and subjected to antigen retrieval with 10 mM trisodium
citrate buffer, pH 6.0 for 20 min at 95 °C. Blocking of 1 h with 1% BSA was
followed by incubation with primary and secondary antibodies. Primary antibodies
were: rabbit anti-ERα (1:100–400; MC20, sc-542 SantaCruz), rabbit anti-PR (1:400;
SP2, RM-9102 Thermo Fisher Scientiﬁc), anti-SMA (1:100; RB-9010-P0; Thermo
Fisher Scientiﬁc), anti-p63 (1:100; MU418-UC; BioGenex) and rabbit anti-RFP
(1:400; cat# PM005, MBL). All secondary antibodies were used at 1:500 dilutions
(Molecular probes): alexa 488-conjugated anti-rabbit IgG, alexa 488-conjugated
anti-goat IgG, alexa 568-conjugated anti-rabbit IgG and alexa 568-conjugated anti-
mouse IgG. Nuclei were counterstained for 10 min with DAPI (Sigma) and
mounted with Dabco (0718, Carl Roth). Images were acquired on confocal Zeiss
LSM700 and reassembled with ImageJ software.
RNA extraction and quantitative reverse transcription polymerase chain
reaction(PCR) analysis with sequencing and bioinformatics analysis. Mam-
mary glands #3–5 were homogenised in TRIzol (15596026, Invitrogen), total RNA
was isolated using miRNeasy Micro Kit (217084, Qiagen), and cDNA synthesised
with 250 ng of total RNA using SuperScript VILO cDNA synthesis kit (11754-050
Invitrogen). For high-throughput qPCR, after a step of pre-ampliﬁcation PCR
using TaqMan PreAmp Master Mix kit (PN 4384556A Applied Biosystems), semi-
quantitative real-time PCR analysis in duplicates was performed using EvaGreen
DNA-binding dye with 48.48 dynamic arrays (Fluidigm) on Biomark HD machine
(Fluidigm). Primers used for the pre-ampliﬁcation are composed of a mix of all
primers used at a ﬁnal concentration of 500 nM. Data were analysed and nor-
malised to three housekeeping genes (Gapdh, 36B4 and Hprt) using GenEx soft-
ware (MultiD). Primer sequences: Areg, ACC AAT GAG AAC TCC GCT GCT,
AAG CGA TTC GCC TTT CCC TGA, 36B4, GAA CTT GCT GCA TAG CAG
ACC, CTC CTT GCA ATC TCC CAG AG, Hprt, ACG AGA GGC TCA CTG
CAG AC, GGA GAT TGC GGG TTT ATA ATG, Wnt-4, AGG AGT GCC AAT
ACC AGT TCC, CAG TTC TCC ACT GCT GCA TG, Prlr, GAT CAT TGT GGC
CGT TCT CT, CCA GCA AGT CCT CAC AGT CA, Pgr, AAA CTG CCC AGC
ATG TCG TCT, GCT CTC GTT AGG AAG GCC CA, Itgb1, TTC AGA CTT CCG
CAT TGG CTT TGG, TGG GCT GGT GCA GTT TTG TTC AC, Gapdh, CCA
ATG TGT CCG TCG TGG ATC, GTT GAA GTC GCA GGA GAC AAC.
RNA was extracted from GFP+ FACS-sorted cells using miRNeasy Mini Kit
(Qiagen). Libraries were prepared in two steps. The ﬁrst step was performed with
SMART-Seq v4 ultra low input RNA Kit (Clontech). Brieﬂy, 10 ng of RNA was
reverse transcribed using a oligo dT primer ﬂanked with a proprietary adaptor.
Template switching mechanism was then used to append another proprietary
adaptor on the 3′ end of the cDNA corresponding to the beginning of the mRNA
molecule. A PCR speciﬁc for the aforementioned adaptors was used to create and
amplify double-stranded cDNA molecules. The second step was performed with
Nextera XT kit (Illumina). Brieﬂy, tagmentation of the double-stranded cDNA with
hyperactive Tn5 created fragments of a few hundred bp, ﬂanked with Illumina
proprietary adaptors. DNA was then PCR ampliﬁed with Illumina primers for eight
cycles, generating ﬁnal libraries of ~400 bp (insert plus adaptors). Libraries were
sequenced on Illumina NextSeq 500 instrument with single-end reads of 85nt. Base
calls and Illumina adaptors trimming performed using bcl2fastq v2.18. Clontech
adaptors trimming performed with CLC 9. RNAseq reads were aligned to the
mm10 genome assembly using the web application HTSstation52. For the
differential RNAseq expression analysis we applied the automated analysis pipeline
ASAP53 for 90% top expressed threshold (% of genes kept in the data frame). Lists
of DE analyses were performed using edgeR package. Heatmap was generated using
ClustVist54.
RNA in situ hybridisation. RNAscope assay (Advanced Cell Diagnostics, Cat. No.
323110) was performed according to manufacturer’s protocol on 4 μm depar-
afﬁnized sections and hybridised with probes: Mm-Esr1 (ACD, Cat. No. 432861),
Mm-Areg (ACD, Cat. No. 430501), Mm-Ppib (ACD, Cat. No. 313911, positive
control) and DapB (ACD, Cat. No. 310043, negative control) at 40 °C for 2h and
revealed with TSA Plus-Cy3 (Perkin Elmer, Cat. No. NEL744001KT). Rabbit anti-
PgR (1:400, clone SP2, Thermo Fisher, Cat. No.: RM-9102-P) and rabbit anti-ERα
(1:100; MC20, sc-542 SantaCruz) was incubated overnight at 4 °C and detected
with Alexa 488 or Alexa 568 conjugated goat anti-rabbit (1:1000, Life Technology),
respectively. Images were captured on confocal Zeiss LSM700 and spots quantiﬁed
using QuPath and an in-house script, code available from O. Burri at the Bioi-
maging and Optics platform, EPFL, based on the guide for RNAscope Data
Analysis.
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Hormone measurements. Testosterone, androstenedione, 17α-hydro-
xyprogesterone, corticosterone, 11-deoxycorticosterone and progesterone levels
were measured by LC–MS High Resolution (Q-Exactive, ThermoFisher Scientiﬁc).
Frozen plasma samples were thawed, vortex mixed, centrifuged at 33,000g for
5 min. An aliquot of 50–100 µL was spiked with 10 µL of internal standards. After
diluting the samples with 5% (w/v) phosphoric acid, the analytes were puriﬁed
using a solid phase extraction (Oasis MCX 96-well plate, Waters). The washing
steps were 5% (w/v) NH4OH and 20% (v/v) methanol. The separation column was
an Acquity UPLC HSS T3 column (1.8 µm, 1.0 × 100 mm, Waters), the mobile
phase comprised H2O and 0.01% formic acid in methanol. The liquid chromato-
graphy system was coupled to a Q-Exactive Orbitrap mass spectrometer (Thermo
Scientiﬁc) using a full scan acquisition. The calibrants were certiﬁed standards
(ChromSystems). Estradiol was extracted from 100 to 200 µL plasma with ethyl
acetate: hexane (3:2). The upper organic layer was evaporated under nitrogen
followed by derivatization with dansyl chloride. The separative column was a
Zorbax Eclipse Plus RRHD C18 (Agilent); analysis was carried out on a 6495 Triple
Quad LC/MS–MS (Agilent)55.
Fluorescence activated cell sorting. Mammary glands were pooled for the pre-
paration of single cell suspensions and processed for ﬂow cytometry as described34.
The following conjugated antibodies were used: anti-CD24-PE-Cy7 (560536, BD
Pharmingen), anti-CD49f-APC (313616, Biolegend), anti-CD31-BV421 (563356,
BD Pharmingen), anti-CD45-BV421 (563890, BD Pharmingen) and anti-Ter119-
BV421 (563998, BD Pharmingen). Mammary epithelial cells were sorted on a
FACSAria ﬂow cytometer (Becton Dickinson) or analysed on LSRII ﬂow cytometer
analyser (Becton Dickinson).
Statistical analysis. Statistical analyses were performed with Prism7 software
(GraphPad). Data are shown as means ± SD, or as otherwise speciﬁed. Statistical
signiﬁcance is indicated as follows *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001,
n.s. not signiﬁcant.
Data availability
The transcriptomics data have been deposited in the Gene Expression Omnibus
database under accession code GSE103664;.
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